Observational studyAdvances in therapy2022

Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data.

Rebecca C Arend et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.